Moderna US, Inc.
Princeton, NJ
- UEI
- G5BFKCJLDML6
- CAGE
- 8PTM0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 5 Vaughn Dr, Princeton, NJ 08540, USA
- Website
- modernatx.com
- Founded
- 2010
- Employees
- 1K-5K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$1 |
Contract vehicles
Contract awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| State Of Wisconsin Department Of Health Services | 2605WI5021 | $697,191 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Modernatx, Inc. | Cambridge, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Corporate | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Pfizer Inc. | New York, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Dynavax Technologies Corporation | Emeryville, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Sanofi Pasteur Inc. | Swiftwater, PA | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Moderna US, Inc. is a biotechnology company that develops and manufactures messenger RNA (mRNA) therapeutics and vaccines. The company provides COVID-19 mRNA vaccines to the federal government through contract awards from the Department of Defense and the Department of Health and Human Services.
Moderna US, Inc. has received prime federal contract awards to supply COVID-19 mRNA vaccines in support of preparedness and response efforts. This includes a $7.8 billion firm fixed price contract from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, representing a transfer from the original procuring agency, the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. Under this definitive contract, Moderna will provide continued production and delivery of its mRNA-1273 coronavirus vaccine from its Cambridge, MA facility over a 15-month period ending February 2024. The contract builds on previous COVID-19 vaccine procurements and distributions managed by the Biomedical Advanced Research and Development Authority. Additionally, Moderna was awarded a $7.8 billion definitive contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense for COVID-19 mRNA vaccines, with a period of performance from July 2022 through March 2023.
Moderna US, Inc. holds multiple Federal Supply Schedule contracts to provide drugs, pharmaceuticals, and hematology-related products. This includes a 5-year multiple award Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration valued at $225,000, intended to supply pharmaceuticals and hematology items to support Veterans health services. Moderna also holds a 1-year multiple award indefinite delivery contract with the Centers for Disease Control and Prevention to provide pediatric COVID-19 vaccines, with a potential value of $601 million. Similarly, the company has a 1-year multiple award indefinite delivery contract to supply adult COVID-19 vaccines to the Centers for Disease Control and Prevention, valued at over $400 million.
Quick answers
Is Moderna US, Inc. registered in SAM.gov?
Yes. Moderna US, Inc.'s SAM.gov registration is active through September 14, 2027.
Which contract vehicles does Moderna US, Inc. hold?
Moderna US, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Moderna US, Inc.'s most recent federal award?
Moderna US, Inc.'s most recent federal contract award is This is a continued contract transferred from ACC - jcrd (DOD) to HHS/aspr/barda/CMA for covid-19 vaccinations for… (75A50122C00055), from Office of the Assistant Secretary for Preparedness and Response, on October 1, 2022.
On GovTribe
See Moderna US, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors